MedChemExpress LLC

MedChemExpress LLC, known as MCE, is a supplier of life science reagents, research chemicals and bioactive compounds for scientific research and drug development. The company is headquartered in New Jersey, USA, and has established multiple R&D, production and logistics centers worldwide. Its catalog lists more than 238,000 products, with over 200,000 bioactive molecules spanning signaling pathways such as PI3K/Akt/mTOR, JAK/STAT and MAPK/ERK, plus disease areas including cancer, infection and neurological disease. Suppliers like this let laboratories buy characterized tool compounds off the shelf, so they do not have to synthesize each molecule they need to probe a biological target.

MCE's product lines include inhibitors, compound libraries, recombinant proteins and antibodies, as well as peptides, oligonucleotides, isotope-labeled compounds, fluorescent dyes, reference standards, GMP small molecules and kits for molecular, protein and cell biology. A one-stop compound screening platform offers more than 200 screening libraries and services such as DNA-encoded library screening, virtual screening, high-throughput screening, kinase profiling and affinity mass spectrometry. Custom synthesis, antibody customization, analytical testing and CDMO services round out the offering; in drug discovery, services of this kind help research groups carry work from early target studies toward preclinical development.

MCE also provides HNMR data analysis, bioactivity evaluation, technical consultation and after-sales support, all run under its stated management systems and quality control standards. The company serves more than 13,000 research institutions worldwide, and over 85,700 publications cite the use of its products, including papers in Nature, Science and Cell. The company describes itself as a long-term partner for scientific exploration and pharmaceutical research, a role that reagent suppliers in this field typically play for academic laboratories and industrial drug discovery teams.